Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Perou

Showing results (421-430 of 447) with videos related to

Pageof 45
Sort By:
Nature|June 3, 2016
Proteogenomics connects somatic mutations to signalling in breast cancerPhilipp Mertins, D R Mani, Kelly V Ruggles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus DocetaxelPriyanka Sharma, Sara López-Tarruella, José Angel García-Saenz, et al.
The Lancet. Oncology|July 17, 2025
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysisGuillermo Villacampa, Tomás Pascual, Paolo Tarantino, et al.
Molecular & Cellular Proteomics : MCP|December 4, 2015
An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in CancerKelly V Ruggles, Zuojian Tang, Xuya Wang, et al.
Nature Medicine|May 2, 2018
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialAndrew Tutt, Holly Tovey, Maggie Chon U Cheang, et al.
Nature Genetics|September 8, 2021
A single-cell and spatially resolved atlas of human breast cancersSunny Z Wu, Ghamdan Al-Eryani, Daniel Lee Roden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two CohortsPriyanka Sharma, Sara López-Tarruella, Jose Angel García-Saenz, et al.
Science (New York, N.Y.)|April 23, 2021
Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accidentLindsay M Morton, Danielle M Karyadi, Chip Stewart, et al.
Nature Communications|April 26, 2017
Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenograftsKuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
Cell Reports|August 9, 2018
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast CancerJonathan T Lei, Jieya Shao, Jin Zhang, et al.
Pageof 45

Showing results (421-430 of 447) with videos related to

Sort By:
Pageof 45
Nature|June 3, 2016
Proteogenomics connects somatic mutations to signalling in breast cancerPhilipp Mertins, D R Mani, Kelly V Ruggles, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus DocetaxelPriyanka Sharma, Sara López-Tarruella, José Angel García-Saenz, et al.
The Lancet. Oncology|July 17, 2025
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysisGuillermo Villacampa, Tomás Pascual, Paolo Tarantino, et al.
Molecular & Cellular Proteomics : MCP|December 4, 2015
An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in CancerKelly V Ruggles, Zuojian Tang, Xuya Wang, et al.
Nature Medicine|May 2, 2018
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialAndrew Tutt, Holly Tovey, Maggie Chon U Cheang, et al.
Nature Genetics|September 8, 2021
A single-cell and spatially resolved atlas of human breast cancersSunny Z Wu, Ghamdan Al-Eryani, Daniel Lee Roden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two CohortsPriyanka Sharma, Sara López-Tarruella, Jose Angel García-Saenz, et al.
Science (New York, N.Y.)|April 23, 2021
Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accidentLindsay M Morton, Danielle M Karyadi, Chip Stewart, et al.
Nature Communications|April 26, 2017
Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenograftsKuan-Lin Huang, Shunqiang Li, Philipp Mertins, et al.
Cell Reports|August 9, 2018
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast CancerJonathan T Lei, Jieya Shao, Jin Zhang, et al.
Pageof 45